| EMA number | EMEA/H/C/004171 |
| ATC code | J07BX |
| Authorisation | 12 December 2018 |
| Withdrawn | 21 October 2025 |
| Revision | 7 |
Dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4.2, 4.4 and 4.8). The use of Dengvaxia should be in accordance with official recommendations.